{
    "nctId": "NCT02270931",
    "briefTitle": "A Prospective Longitudinal Breast Cancer Study",
    "officialTitle": "A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence or Progressive Disease in Patients With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 130,
    "primaryOutcomeMeasure": "Measure CA 15-3 in Breast Cancer Patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Males and females, age\u2265 18 years\n* Histologic/pathologic confirmation of breast cancer\n* Any stage of disease: Newly diagnosed, stable, disease progression, surveillance\n* Any treatment time point: Treatment na\u00efve, currently receiving or completed therapy for breast cancer including active monitoring.\n* Individuals with a history of malignant disease other than breast cancer that was resected greater than 5 years ago and are currently in remission are eligible.\n* Able to understand and willing to provide informed consent\n\nExclusion Criteria:\n\n* Males and females, age \\<18 years\n* No histologic/pathologic confirmation of breast cancer\n* Any concurrent malignancy other than basal or squamous cell skin cancers, in-situ cervical cancer, or breast cancer.\n* Treatment plan with fewer than three visits expected in 3 years' time\n* Unable to provide informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}